Karen Stanek
Physical Medicine & Rehabilitation · Spokane, WANPI 1225017411
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,030 of the $18,983 with a category attached, or 73.9%. Ipsen Biopharmaceuticals, Inc accounts for 88.0% of it on its own, with 23 other manufacturers making up the rest. 2024 is the largest year on record at $9,740, 2.1 times the $4,538 reported in 2019. Among physical medicine & rehabilitation clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $123.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$17K
- AbbVie$571
- Collegium Pharmaceutical, Inc.$263
- Lilly USA, LLC$250
- Merz North America, Inc.$165
- Merz Pharmaceuticals, LLC$156
- plus $867 from 18 others
What the payments were for
- Speaking & faculty fees$14,03074%
- Travel & lodging$1,4298%
- Food & beverage$3,46518%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 33 | $16,711 |
| AbbVie(2 entities) | 33 | $571 |
| Collegium Pharmaceutical, Inc. | 17 | $263 |
| Lilly USA, LLC | 14 | $250 |
| Merz North America, Inc. | 7 | $165 |
| Merz Pharmaceuticals, LLC | 6 | $156 |
| Amgen | 5 | $154 |
| Smith+Nephew | 4 | $100 |
| Biohaven Pharmaceuticals, Inc. | 5 | $82 |
| Saol Therapeutics Inc. | 2 | $79 |
| Medtronic(2 entities) | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Pfizer | 3 | $54 |
| Piramal Critical Care | 3 | $46 |
| Novartis | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Nevro Corp. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Strongbridge US Inc. | 1 | $16 |
| Eisai Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DYSPORT$16,067
How this compares
$18,983 in reported general payments places this provider in the 95th percentile of 260 physical medicine & rehabilitation providers in Washington.
See all physical medicine & rehabilitation providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other physical medicine & rehabilitation in Spokane
- Ross BogeySpokane$4K
- Aaron KingSpokane$3K
- Patrick SotoSpokane$3K
- John LongSpokane$2K
- Natalie CooperSpokane$1K
- Ryan BarnesSpokane$792
- Nassim RadSeattle$231K
- Nelson HagerTacoma$186K
- Martin ChildersSeattle$170K
- Theodore BrownKirkland$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.